84 results
Page 3 of 5
S-8
EX-99.1
4c4wvvyamg2
27 Feb 20
Registration of securities for employees
12:00am
424B5
5lut8qhscvgxugzaivp
9 Jan 20
Prospectus supplement for primary offering
5:25pm
8-K
EX-1.1
706 u1hz5
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
424B5
77t7fq85 k7
7 Jan 20
Prospectus supplement for primary offering
4:19pm
S-3ASR
EX-4.3
ylqvy i4a
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
q2o6uhi6b7y
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
ngz7voug5bqrlbnl zef
7 Jan 20
Automatic shelf registration
4:01pm
8-K
EX-10.1
t005vbtarnf9h7ixrnkt
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
8-K
fxd6i
7 Oct 19
Departure of Directors or Certain Officers
4:06pm
POS AM
EX-1.2
j07dc7 tit5nzenfli
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
POS AM
ctcxhxwjoo5ipm0eide
4 Oct 19
Prospectus update (post-effective amendment)
4:59pm
8-K
EX-4.1
q4cw 7q65w2
16 Sep 19
Apellis Pharmaceuticals Announces Closing of Offering of Convertible Senior Notes
5:17pm